Ryan Vann

Partner

rhvann@cooley.com

Full contact info

I help manage human capital. My job is to help make effective decisions during the employment life cycle and to resolve disputes arising from employment relationships.

About Ryan

Ryan is a founding partner of Cooley’s Chicago office and assists clients with labor and employment counseling, litigation and complex transactional needs. He guides employers through all phases of the employment cycle, including hiring considerations, restrictive covenants, disciplinary advice, leave management, employment separation and enforcement of restrictive covenant obligations. Ryan has substantial experience in both large-scale reductions in force and both high-profile routine individual employee separations. He has also led several misconduct investigations of high-level executives and guides employers through day-to-day issues and crisis counseling in emergency situations, including those arising from the COVID-19 pandemic.

View full bio

Passions

Kiddos

Wilderness Camping

Cycling

Hoosier Basketball

Experience

Araris Biotech’s up to $1.14 Billion Acquisition by Taiho Pharmaceutical

March 17, 2025

Cooley advised Araris Biotech, a Swiss biotechnology company developing next-generation antibody-drug conjugates, on its definitive agreement to be acquired by Japan-based Taiho Pharmaceutical for up to $1.14 billion in cash.

Related contacts

Bill Roegge

Partner, New York

Kenneth Krisko

Partner, Reston

Simon Amies

Partner, London

Rita Sobral

Special Counsel, London

Stephanie Parker Palmer

Special Counsel, Reston

Michael Bergmann

Partner, Washington, DC

Brandon W. Fenn

Partner, New York

Eileen Marshall

Partner, Washington, DC

Jeremy Morrison

Partner, Washington, DC

Dr. Matthew Pavao

Partner, Boston

Stella Sarma

Partner, Brussels

Ryan Vann

Partner, Chicago

Natasha Leskovsek

Of Counsel, Washington, DC

Elizabeth Caruso

Associate, New York

Matthew Choy

Associate, New York

Kyle Hess

Associate, New York

Katie Kaufman

Associate, Boston

Edward (Teddy) Nimetz

Associate, New York

Alexandra Paterson

Associate, London

Joseph Perry

Associate, Reston

Dr. Robert E. Powers

Associate, Boston

María Álvarez Requejo Heredero

Associate, Brussels

Related Practices & Industries

Mergers and Acquisitions

Life Sciences Corporate Partnering and Licensing

Emerging Companies

Biotechnology

Life Sciences

Healthcare

Life Sciences and Healthcare Regulatory

Labor and Employment

Tax

Patent Counseling and Prosecution

Antitrust and Competition

Cooley Advises Special Committee of Checkpoint on Acquisition by Sun Pharma

March 9, 2025

Cooley advised the special committee of Checkpoint Therapeutics’ (Nasdaq: CKPT) board of directors in connection with Checkpoint’s definitive agreement to be acquired by Sun Pharmaceutical Industries (NSE: SUNPHARMA) for up to $416 million in cash and contingent value rights.

Related contacts

Bill Roegge

Partner, New York

Kevin Cooper

Partner, New York

Marc Recht

Partner, Boston

Wesley Dietrich

Associate, Washington, DC

Katie Benvenuti

Associate, New York

Michael Bergmann

Partner, Washington, DC

Eileen Marshall

Partner, Washington, DC

Alan W. Tamarelli

Partner, New York

Julia R. Brinton

Special Counsel, Washington, DC

Kristopher Kleiner

Special Counsel, Colorado

Rebecca Ross

Special Counsel, Washington, DC

Stella Sarma

Partner, Brussels

Natasha Leskovsek

Of Counsel, Washington, DC

Karun Ahuja

Special Counsel, Chicago

Elizabeth Caruso

Associate, New York

Matthew Choy

Associate, New York

Jameson Davis

Associate, Boston

Kyle Hess

Associate, New York

Allison Kutner

Associate, New York

Breanna Qin

Associate, Palo Alto

Arda Can Tekin

Associate, New York

Ryan Vann

Partner, Chicago

Related Practices & Industries

Mergers and Acquisitions

Life Sciences

Healthcare

Capital Markets

Cyber/Data/Privacy

Antitrust and Competition

Compensation and Benefits

Life Sciences Corporate Partnering and Licensing

Tax

Labor and Employment

Life Sciences and Healthcare Regulatory

CFIUS

Egnyte Announces Majority Investment From GI Partners and TA Associates

February 25, 2025

Cooley advised Egnyte, a provider of secure content collaboration and governance solutions, on its strategic growth investment from GI Partners and TA Associates.

Related contacts

Eric Jensen

Senior Counsel, Palo Alto

Sepideh Mousakhani

Partner, Palo Alto

Anne Lieberman

Partner, Santa Monica

Steve Tonsfeldt

Partner, Palo Alto

Kealan Santistevan

Associate, Palo Alto

Sangitha Palaniappa

Associate, Palo Alto

Michael Bergmann

Partner, Washington, DC

Brett De Jarnette

Partner, Palo Alto

Patrick Flanagan

Partner, New York

Todd Gluth

Partner, San Diego

Tracy Rubin

Partner, Palo Alto

Stella Sarma

Partner, Brussels

Timothy Shapiro

Partner, Palo Alto

David Silverman

Partner, New York

Ryan Vann

Partner, Chicago

Summer Wynn

Partner, San Diego

Howard Morse

Senior Counsel, Washington, DC

Sharon Connaughton

Special Counsel, Washington, DC

Kristopher Kleiner

Special Counsel, Colorado

Rebecca Ross

Special Counsel, Washington, DC

Karen Tsai

Special Counsel, Washington, DC

Nathan Alamillo

Associate, Santa Monica

Caitlin Breitenbruck

Associate, Seattle

Norma Chayo Dichi

Associate, Washington, DC

Queenie Chen

Associate, Palo Alto

Nikki Chang DiFederico

Associate, Palo Alto

Megan Drill

Associate, San Diego

Jeremy M. Exelbert

Associate, New York

Nathaniel Hearn Jr.

Associate, Chicago

Vicky Kandabarow

Associate, Washington, DC

Nicollette R. Kirby

Associate, Washington, DC

Allison Kutner

Associate, New York

Alexandra Leavy

Associate, New York

Emily Lee

Associate, Palo Alto

Narmada Murugan

Associate, Palo Alto

Michael Pelle

Associate, New York

Katie Stevens

Associate, Palo Alto

Rubin Waranch

Associate, Colorado

Kevin Gurley

Quantitative Analyst, New York

Brian Mitchell

Transactional Quantitative Analyst, San Diego

Related Practices & Industries

Mergers and Acquisitions

Emerging Companies

Capital Markets

Tax

Compensation and Benefits

Antitrust and Competition

Technology Transactions

Technology

Cloud Solutions

Labor and Employment

Debt Finance

Cyber/Data/Privacy

CFIUS

Private Equity

Commercial Litigation

Securities Litigation + Enforcement

MongoDB Announces Acquisition of Voyage AI

February 24, 2025

Cooley advised MongoDB (Nasdaq: MDB), a leading database for modern applications, on its acquisition of Voyage AI, a pioneer in state-of-the-art embedding and reranking models that power next-generation artificial intelligence applications.

Related contacts

Kevin Cooper

Partner, New York

Christine Tse

Associate, New York

Thomas Connors

Partner, Boston

Annie Froehlich

Partner, Washington, DC

Barbara Mirza

Partner, Santa Monica

Phil Mitchell

Partner, New York

John Paul Oleksiuk

Partner, New York

Miriam Petrillo

Partner, Chicago

Jonathan Rivinus

Partner, Colorado

Ryan Vann

Partner, Chicago

Mark Windfeld-Hansen

Senior Counsel, Palo Alto

Sharon Connaughton

Special Counsel, Washington, DC

Reid Hooper

Special Counsel, Washington, DC

Kristopher Kleiner

Special Counsel, Colorado

Dillon Martinson

Special Counsel, Washington, DC

Megan Drill

Associate, San Diego

Jimmy Gilligan

Associate, Boston

Liza Hadley

Associate, Boston

Wyatt Kernell

Associate, Colorado

Allison Kutner

Associate, New York

Caolinn Mejza

Associate, New York

Lois NaYeon Yoo

Associate, New York

Leanne Andrepont

Senior Trademark Paralegal

Jake Ironfield

Transactional Quantitative Analyst, New York

Related Practices & Industries

Mergers and Acquisitions

Artificial Intelligence

Technology Transactions

Technology

Tax

Compensation and Benefits

Cyber/Data/Privacy

Labor and Employment

CFIUS

Antitrust and Competition

Life Sciences and Healthcare Regulatory

Capital Markets

Trademark, Copyright and Advertising

Patent Counseling and Prosecution

Tempus Announces $600 Million Acquisition of Ambry Genetics

November 4, 2024

Cooley advised Tempus AI (Nasdaq: TEM), a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, on its agreement to acquire Ambry Genetics, a company focusing on genetic testing that aims to improve health by understanding the relationship between genetics and disease.